Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

Suppr

超能文献

作者信息

Akhtar S, Rossi J J

机构信息

Pharmaceutical Sciences Institute, Aston University, Birmingham, UK.

出版信息

J Antimicrob Chemother. 1996 Aug;38(2):159-65. doi: 10.1093/jac/38.2.159.

DOI:10.1093/jac/38.2.159

PMID:8877530

Abstract

摘要

相似文献

Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

J Antimicrob Chemother. 1996 Aug;38(2):159-65. doi: 10.1093/jac/38.2.159.

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.

Hepatology. 1997 Aug;26(2):251-5. doi: 10.1002/hep.510260237.

Therapeutic antisense and ribozymes.

Br Med Bull. 1995 Jan;51(1):217-25. doi: 10.1093/oxfordjournals.bmb.a072948.

RNA as a target for developing antivirals.

Antivir Chem Chemother. 2003 Mar;14(2):61-73. doi: 10.1177/095632020301400201.

RNA enzymes (ribozymes) as antiviral therapeutic agents.

Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x.

Ribozymes: use as anti-HIV therapeutic molecules.

Antisense Res Dev. 1993 Spring;3(1):87-94. doi: 10.1089/ard.1993.3.87.

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9.

Gene therapy for HIV.

Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93.

Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.

Biochem Mol Med. 1997 Oct;62(1):11-22. doi: 10.1006/bmme.1997.2631.

Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance.

Methods Mol Med. 2005;106:215-33. doi: 10.1385/1-59259-854-4:215.

引用本文的文献

Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.

AAPS PharmSci. 2001;3(1):E7. doi: 10.1208/ps030107.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

J Antimicrob Chemother. 1996 Aug;38(2):159-65. doi: 10.1093/jac/38.2.159.

Gene therapy for chronic viral hepatitis: ribozymes, antisense oligonucleotides, and dominant negative mutants.

Hepatology. 1997 Aug;26(2):251-5. doi: 10.1002/hep.510260237.

Therapeutic antisense and ribozymes.

Br Med Bull. 1995 Jan;51(1):217-25. doi: 10.1093/oxfordjournals.bmb.a072948.

RNA as a target for developing antivirals.

Antivir Chem Chemother. 2003 Mar;14(2):61-73. doi: 10.1177/095632020301400201.

RNA enzymes (ribozymes) as antiviral therapeutic agents.

Trends Biotechnol. 1990 Jul;8(7):179-83. doi: 10.1016/0167-7799(90)90169-x.

Ribozymes: use as anti-HIV therapeutic molecules.

Antisense Res Dev. 1993 Spring;3(1):87-94. doi: 10.1089/ard.1993.3.87.

Catalytic antisense RNA (ribozymes): their potential and use as anti-HIV-1 therapeutic agents.

Adv Exp Med Biol. 1992;312:95-109. doi: 10.1007/978-1-4615-3462-4_9.

Gene therapy for HIV.

Sex Transm Infect. 2001 Apr;77(2):93-6. doi: 10.1136/sti.77.2.93.

Therapeutic potential and mechanism of action of oligonucleotides and ribozymes.

Biochem Mol Med. 1997 Oct;62(1):11-22. doi: 10.1006/bmme.1997.2631.

Utility of antioncogene ribozymes and antisense oligonucleotides in reversing drug resistance.

Methods Mol Med. 2005;106:215-33. doi: 10.1385/1-59259-854-4:215.

引用本文的文献

Lipid-based delivery of combinations of antisense oligodeoxynucleotides for the in vitro inhibition of HIV-1 replication.

AAPS PharmSci. 2001;3(1):E7. doi: 10.1208/ps030107.